1.Schettler T. Human exposure to phthalates via consumer products. Int J Androl. 2006; 29, 134–139.
2.Wormut M. What are the sources of exposure to eight frequently used phthalic esters in Europeans? Risk Anal. 2006; 26, 803–824.
3.Hoppin JA, Brock JW, Davis BJ, Baird DD. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect. 2002; 110, 515–518.
4.Hauser R, Meeker JD, Park S, Silva MJ, Calafat AM. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect. 2004; 112, 1734–1740.
5.Teitelbaum SL, Britton JA, Calafat AM, et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ Res. 2008; 106, 257–269.
6.Masutomi N, Shibutani M, Takagi H, et al. Impact of dietary exposure to methoxychlor, genistein, or diisononyl phthalate during the perinatal period on the development of the rat endocrine/reproductive systems in later life. Toxicology. 2002; 192, 149–170.
7.Parks LG, Ostby JS, Lambright CR, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000; 58, 339–349.
8.Ema M, Miyawaki E. Adverse effects on development of the reproductive system in male offspring of rats given monobutyl phthalate, a metabolite of dibutyl phthalate during late pregnancy. Reprod Toxicol. 2001; 15, 189–194.
9.Gray TJB, Beamand JA. Effect of some phthalate esters and other testicular toxins on primary cultures of testicular cells. Food Chem Toxicol. 1984; 22, 123–131.
10.Nakahara H, Shono T, Suita S. Effects of prenatal exposure to phthalate ester on both testicular descent and urogenital development in rats. Fukuoka Igaku Zasshi. 2003; 94, 331–337.
11.Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005; 113, 1056–1061.
12.Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res. 2008; 108, 177–184.
13.Suzuki Y, Yoshinaga J, Mizumoto Y, Serizawa S, Shiraishi H. Foetal exposure to phthalate esters and anogenital distance in male newborns. Intl J Androl. 2012; 35, 236–244.
14.Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int. 2009; 35, 14–20.
15.Salazar-Martínez E, Romano-Riquer P, Yáñez-Márquez E, Longnecker MP, Hernandez-Avila M. Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health. 2005; 3, 8–13.
16.Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr. 1978; 93, 120–122.
17.Albro PW, Jordan ST, Schroeder JL, Corbett JT. Chromatographic separation and quantitative determination of metabolites of di-(2 ethylhexyl)phthalate from urine of laboratory animals. J Chromatogr. 1982; 244, 65–79.
18.Blount BC, Milgram KE, Silva MJ, et al. Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem. 2000; 72, 4127–4134.
19.García MA, Soberón E, Cortez M, Rodríguez R, Herrera JL. Métodos analíticos Guía de validación; Colegio Nacional de Químicos Farmacéuticos Biólogos A. C: México 2002.
20.Adibi JJ, Whyatt RM, Paige LW, et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect. 2008; 116, 467–473.
21.Svensson K, Hernández-Ramírez RU, Burguete-García A, et al. Phthalate exposure associated with self-reported diabetes among Mexican women. Environ Res. 2011; 111, 792–796.
22.Romero-Franco M, Hernández-Ramírez RU, Calafat AM, et al. Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int. 2011; 37, 867–871.
23.Romano-Riquer SP, Hernández-Ávila M, Gladen BC, Cupul-Uicab LA, Longnecker MP. Reliability and determinants of anogenital distance and penis dimensions in male newborns from Chiapas, Mexico. Paediatr Perinat Epidemiol. 2007; 21, 219–228.
24.Fok TF, Hon KL, So HK, et al. The Hong Kong Neonatal Measurements Working Group. Normative data of penile length for term Chinese newborns. Biol Neonate. 2005; 87, 242–245.
25.Anigstein CR. Longitud y diámetro del pene en niños de 0 a 14 años de edad. Arch Argent Pediatr. 2005; 103, 401–405.
26.Damon V, Berlier P, Durozier B, Francois R. Study of the dimensions of the penis from birth to adult age and as a function of testicular volume. Pediatrie. 1990; 45, 519–522.
27.Carmudan AD, Oz MO, Ilhan MN, et al. Current stretched penile length: cross-sectional study of 1040 healthy Turkish children aged 0 to 5 years. Urology. 2007; 70, 572–575.
28.Al-Herbish AS. Standard penile size for normal full term newborns in the Saudi population. Saudi Med J. 2002; 23, 314–316.
29.Fujieda K, Matsuura N. Growth and maturation in male genitalia from birth to adolescence II. Change of penile length. Pediatr Int. 1987; 29, 220–223.
30.Lee PA, Mazur T, Danish R, et al. Micropenis I. Criteria, etiologies and classification. Johns Hopkins Med J. 1980; 146, 156–163.
31.Anhalt H, Neely EK, Hintz RL. Ambiguous genitalia. Pediatr Rev. 1996; 17, 213–220.
32.Mendiola J, Stahlnut RW, Jorgensen N, Liu F, Swan SH. Shorter anogenital distance predicts poorer semen quality in young men in Rochester, New York. Environ Health Pers. 2011; 119, 958–963.
33.Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PMD. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rats. Toxicol Sci. 2003; 74, 393–406.
34.Ge RS, Chen GR, Tanrikut C, Hardy MP. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations. Reprod Toxicol. 2007; 23, 366–373.
35.Chen GR, Dong L, Ge RS, Hardy MP. Relationship between phthalates and testicular dysgenesis syndrome. Zhonghua Nan Ke Xue. 2007; 13, 195–200.
36.Welsh M, Saunders PTK, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008; 118, 1479–1490.